T-lymphocyte activation increases hypothalamic and amygdaloid expression of CRH mRNA and emotional reactivity to novelty

Journal of Neuroscience

Volumn 19, Issue 11, 1999, Pages 4533-4543

  Kusnecov, Alexander W ^a   Liang, Rumei ^b   Shurin, Galina ^b  

^a RUTGERS UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenocorticotropic hormone; Amygdala; Corticotropin releasing hormone; Cytokines; Emotion; Hypothalamus; Interleukin 2; Neophobia; Prostaglandins; Psychoneuroimmunology; Staphylococcal enterotoxin B; Stress; T lymphocytes

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; INDOMETACIN; INTERLEUKIN 2; MESSENGER RNA; PROSTAGLANDIN; STAPHYLOCOCCUS ENTEROTOXIN B;

AFFECTIVE NEUROSIS; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITION; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CYTOKINE PRODUCTION; EMOTIONALITY; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN SITU HYBRIDIZATION; MALAISE; MALE; MENTAL STRESS; MOUSE; NEOPHOBIA; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; T LYMPHOCYTE ACTIVATION; TASTE AVERSION; THALAMUS MIDLINE NUCLEUS;

EID: 0033151625     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.19-11-04533.1999     Document Type: Article

References (68)

1. Aird F, Clevenger CV, Prystowsky MB, Redei E (1993) Corticotropin-releasing factor mRNA in rat thymus and spleen. Proc Natl Acad Sci USA 90:7104-7108.
2. Anisman H, Zacharko RM (1992) Depression as a consequence of inadequate neurochemical adaptation in response to stressors. Br J Psychiatry [Suppl] 36-43.
3. Anisman H, Zalcman S, Zacharko RM (1993) The impact of stressors on immune and central neurotransmitter activity: bidirectional communication. Rev Neurosci 4:147-180.
4. Anisman H, Kokkinidis L, Merali Z (1996) Interleukin-2 decreases accumbal dopamine efflux and responding for rewarding lateral hypothalamic stimulation. Brain Res 731:1-11.
5. Bamberger CM, Wald M, Bamberger AM, Ergun S, Beil FU, Schulte HM (1998) Human lymphocytes produce urocortin, but not corticotropin-releasing hormone. J Clin Endocrinol Metab 83:708-711.
6. Berkenbosch F, Van Oers J, Del Rey A, Tilders F, Besedovsky H (1987) Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 238:524-526.
7. Besedovsky HO, Del Rey A (1996) Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 17:64-102.
8. Bette M, Schafer MK, Van Rooijen N, Weihe E, Fleischer B (1993) Distribution and kinetics of superantigen-induced cytokine gene expression in mouse spleen. J Exp Med 178:1531-1539.
9. Brady LS, Lynn AB, Herkenham M, Gottesfeld Z (1994) Systemic interleukin-1 induces early and late patterns of c-fos mRNA expression in brain. J Neurosci 14:4951-4964.
10. Brouxhon SM, Prasad AV, Joseph SA, Felten DL, Bellinger DL (1998) Localization of corticotropin-releasing factor in primary and secondary lymphoid organs of the rat. Brain Behav Immunol 12:107-122.
11. Buller KM, Xu Y, Day TA (1998) Indomethacin attenuates oxytocin and hypothalamic-pituitary-adrenal axis responses to systemic interleukin-1β. J Neuroendocrinol 10:519-528.
12. Connor TJ, Song C, Leonard BE, Merali Z, Anisman H (1998) An assessment of the effects of central interleukin-1β, -2, -6, and tumor necrosis factor-α administration on some behavioural, neurochemical, endocrine, and immune parameters in the rat. Neuroscience 84:923-933.
13. Davis M (1992) The role of the amygdala in fear and anxiety. Annu Rev Neurosci 15:353-375.
14. Derijk R, Van Rooijen N, Tilders FJ, Besedovsky HO, Del Rey A, Berkenbosch F (1991) Selective depletion of macrophages prevents pituitary-adrenal activation in response to subpyrogenic, but not to pyrogenic, doses of bacterial endotoxin in rats. Endocrinology 129:330-338.
15. Dunn AJ (1993) Infection as a stressor: a cytokine-mediated activation of the hypothalamo-pituitary-adrenal axis? Ciba Found Symp [Discussion 172:239-242] 172:226-239.
16. Dunn AJ, Berridge CW (1990) Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Brain Res Rev 15:71-100.
17. Dunn AJ, Antoon M, Chapman Y (1991) Reduction of exploratory behavior by intraperitoneal injection of interleukin-1 involves brain corticotrophin-releasing factor. Brain Res Bull 26:539-542.
18. Exton MS, Bull DF, King MG (1995) Behavioral conditioning of lipopolysaccharide-induced anorexia. Physiol Behav 57:401-405.
19. Florquin S, Amraoui Z, Abramowicz D, Goldman M (1994) Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. J Immunol 153:2618-2623.
20. Gonzalo JA, Gonzalez-Garcia A, Martinez C, Kroemer G (1993) Glucocorticoid-mediated control of the activation and clonal deletion of peripheral T-cells in vivo. J Exp Med 177:1239-1246.
21. Gonzalo JA, Baixeras E, Gonzalez-Garcia A, George-Chandy A, Van Rooijen N, Martinez C, Kroemer G (1994) Differential in vivo effects of a superantigen and an antibody targeted to the same T-cell receptor. Activation-induced cell death vs passive macrophage-dependent deletion. J Immunol 152:1597-1608.
22. Haas HS, Schauenstein K (1997) Neuroimmunomodulation via limbic structures - the neuroanatomy of psychoimmunology. Prog Neurobiol 51:195-222.
23. Hanisch UK, Quirion R (1995) Interleukin-2 as a neuroregulatory cytokine. Brain Res Brain Res Rev 21:246-284.
24. Hanisch UK, Rowe W, Sharma S, Meaney MJ, Quirion R (1994) Hypothalamic-pituitary-adrenal activity during chronic central administration of interleukin-2. Endocrinology 135:2465-2472.
25. Hebb AL, Zacharko RM, Anisman H (1998) Self-stimulation from the mesencephalon following intraventricular interleukin-2 administration. Brain Res Bull 45:549-556.
26. Heilig M, Koob GF, Ekman R, Britton KT (1994) Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci 17:80-85.
27. Herman JP, Cullinan WE (1997) Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 20:78-84.
28. Hsu DT, Chen FL, Takahashi LK, Kalin NH (1998) Rapid stress-induced elevations in corticotropin-releasing hormone mRNA in rat central amygdala nucleus and hypothalamic paraventricular nucleus - an in situ hybridization analysis. Brain Res 788:305-310.
29. Imaki T, Xiao-Quan W, Shibasaki T, Yamada K, Harada S, Chikada N, Naruse M, Demura H (1995) Stress-induced activation of neuronal activity and corticotropin-releasing factor gene expression in the paraventricular nucleus is modulated by glucocorticoids in rats. J Clin Invest 96:231-238.
30. Janz LJ, Green-Johnson J, Murray L, Vriend CY, Nance DM, Greenberg AH, Dyck DG (1996) Pavlovian conditioning of LPS-induced responses: effects on corticosterone, splenic NE, and IL-2 production. Physiol Behav 59:1103-1109.
31. Johnson HM, Russell JK, Pontzer CH (1991) Staphylococcal enterotoxin microbial superantigens. FASEB J 5:2706-2712.
32. Keegan CE, Herman JP, Karolyi IJ, O'Shea KS, Camper SA, Seasholtz AF (1994) Differential expression of corticotropin-releasing hormone in developing mouse embryos and adult brain. Endocrinology 134:2547-2555.
33. + T-cells and clones activated in vivo and in vitro. Immunol Rev 123:85-114.
34. Kent S, Kelley KW, Dantzer R (1992) Effects of lipopolysaccharide on food-motivated behavior in the rat are not blocked by an interleukin-1 receptor antagonist. Neurosci Lett 145:83-86.
35. Kotzin BL, Leung DY, Kappler J, Marrack P (1993) Superantigens and their potential role in human disease. Adv Immunol 54:99-166.
36. Kovacs KJ, Sawchenko PE (1996) Sequence of stress-induced alterations in indices of synaptic and transcriptional activation in parvocellular neurosecretory neurons. J Neurosci 16:262-273.
37. Lacosta S, Merali Z, Anisman H (1998) Influence of interleukin-1β on exploratory behaviors, plasma ACTH, corticosterone, and central biogenic amines in mice. Psychopharmacology 137:351-361.
38. Laflamme N, Barden N, Rivest S (1997) Corticotropin-releasing factor and glucocorticoid receptor (GR) gene expression in the paraventricular nucleus of immune-challenged transgenic mice expressing type II GR antisense ribonucleic acid. J Mol Neurosci 8:165-179.
39. Litton MJ, Sander B, Murphy E, O'Garra A, Abrams JS (1994) Early expression of cytokines in lymph nodes after treatment in vivo with Staphylococcus enterotoxin B. J Immunol Methods 175:47-58.
40. London CA, Abbas AK, Kelso A (1998) Helper T-cell subsets: heterogeneity, functions, and development. Vet Immunol Immunopathol 63:37-44.
41. Maes M (1995) Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 19:11-38.
42. Maier SF, Watkins LR (1995) Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Res 695:279-282.
43. Maier SF, Watkins LR (1998) Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 105:83-107.
44. Marrack P, Winslow GM, Choi Y, Scherer M, Pullen A, White J, Kappler JW (1993) The bacterial and mouse mammary tumor virus superantigens: two different families of proteins with the same functions. Immunol Rev 131:79-92.
45. Merali Z, McIntosh J, Kent P, Michaud D, Anisman H (1998) Aversive and appetitive events evoke the release of corticotropin-releasing hormone and bombesin-like peptides at the central nucleus of the amygdala. J Neurosci 18:4758-4766.
46. 14C plastic standards for quantitative autoradiography using LKB ultrofilm or Amersham hyperfilm. Neurosci Lett 121:211-214.
47. Montkowski A, Landgraf R, Yassouridis A, Holsboer F, Schobitz B (1997) Central administration of IL-1 reduces anxiety and induces sickness behaviour in rats. Pharmacol Biochem Behav 58:329-336.
48. Muglia LJ, Jenkins NA, Gilbert DJ, Copeland NG, Majzoub JA (1994) Expression of the mouse corticotropin-releasing hormone gene in vivo and targeted inactivation in embryonic stem cells. J Clin Invest 93:2066-2072.
49. Owens MJ, Nemeroff CB (1991) Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43:425-473.
50. Plata-Salaman CR (1996) Anorexia during acute and chronic disease [see comments; review]. Nutrition 12:69-78.
51. Raber J, Koob GF, Bloom FE (1995) Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling: comparison with the hypothalamic response. J Pharmacol Exp Ther 272:815-824.
52. Rassnick S, Heinrichs SC, Britton KT, Koob GF (1993) Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res 605:25-32.
53. Rodriguez dF, Carrera MA, Navarro M, Koob GF, Weiss F (1997) Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 276:2050-2054.
54. Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W (1987) Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238:522-524.
55. Schrott LM, Crnic LS (1996) Increased anxiety behaviors in autoimmune mice. Behav Neurosci 110:492-502.
56. Schrott LM, Crnic LS (1998) Attenuation of behavioral abnormalities in autoimmune mice by chronic soluble interferon-gamma receptor treatment. Brain Behav Immunol 12:90-106.
57. Shurin G, Shanks N, Nelson L, Hoffman G, Huang L, Kusnecov AW (1997) Hypothalamic-pituitary-adrenal activation by the bacterial superantigen staphylococcal enterotoxin B: role of macrophages and T-cells. Neuroendocrinology 65:18-28.
58. Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH, Chen R, Marchuk Y, Hauser C, Bentley CA, Sawchenko PE, Koob GF, Vale W, Lee KF (1998) Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20:1093-1102.
59. Spadaro F, Dunn AJ (1990) Intracerebroventricular administration of interleukin-1 to mice alters investigation of stimuli in a novel environment. Brain Behav Immunol 4:308-322.
60. Stenzel-Poore MP, Cameron VA, Vaughn J, Sawchenko PE, Vale W (1992) Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. Endocrinology 130:3378-3386.
61. Stout JC, Weiss JM (1994) An animal model for measuring behavioral responses to anxiogenic and anxiolytic manipulations. Pharmacol Biochem Behav 47:459-465.
62. Troutt AB, Maraskovsky E, Rogers LA, Pech MH, Kelso A (1992) Quantitative analysis of lymphokine expression in vivo and in vitro. Immunol Cell Biol 70:51-57.
63. Van de Kar LD, Piechowski RA, Rittenhouse PA, Gray TS (1991) Amygdaloid lesions: differential effect on conditioned stress and immobilization-induced increases in corticosterone and renin secretion. Neuroendocrinology 54:89-95.
64. Walker LG, Wesnes KP, Heys SD, Walker MB, Lolley J, Eremin O (1996) The cognitive effects of recombinant interleukin-2 (rIL-2) therapy: a controlled clinical trial using computerized assessments. Eur J Cancer [A] 32:2275-2283.
65. Walker LG, Walker MB, Heys SD, Lolley J, Wesnes K, Eremin O (1997) The psychological and psychiatric effects of rIL-2 therapy: a controlled clinical trial. Psychooncology 6:290-301.
66. Wood AC, Todd I (1995) Staphylococcal enterotoxin B toxicity in BALB/c mice: effect on T-cells, plasma cytokine levels, and biochemical markers. FEMS Immunol Med Microbiol 11:91-97.
67. Yamamoto T, Shimura T, Sako N, Yasoshima Y, Sakai N (1994) Neural substrates for conditioned taste aversion in the rat. Behav Brain Res 65:123-137.
68. Zalcman S, Green-Johnson JM, Murray L, Nance DM, Dyck D, Anisman H, Greenberg AH (1994) Cytokine-specific central monoamine alterations induced by interleukin-1, -2, and -6. Brain Res 643:40-49.